1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Thinness: new trials by email Literature Review of Thinness trials Research Report on Thinness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis Interferon beta-1a, Fingolimod, Placebo capsule - Multiple Sclerosis | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 240 | 2013-07-26 | 2026-08-10 |
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Body Weight (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Fingolimod Hydrochloride (1) · Interferon beta-1a (1)
Australia (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Croatia (1) · Estonia (1) · France (1) · Germany (1) · Italy (1) · Latvia (1) · Lithuania (1) · Mexico (1) · Netherlands (1) · Poland (1)